| Literature DB >> 18602262 |
Richard M Angell1, Tony D Angell, Paul Bamborough, Mark J Bamford, Chun-wa Chung, Stuart G Cockerill, Stephen S Flack, Katherine L Jones, Dramane I Laine, Timothy Longstaff, Steve Ludbrook, Rosannah Pearson, Kathryn J Smith, Penny A Smee, Don O Somers, Ann L Walker.
Abstract
The biphenyl amides (BPAs) are a series of p38alpha MAP kinase inhibitors. Compounds are able to bind to the kinase in either the DFG-in or DFG-out conformation, depending on substituents. X-ray, binding, kinetic and cellular data are shown, providing the most detailed comparison to date between potent compounds from the same chemical series that bind to different p38alpha conformations. DFG-out-binding compounds could be made more potent than DFG-in-binding compounds by increasing their size. Unexpectedly, compounds that bound to the DGF-out conformation showed diminished selectivity. The kinetics of binding to the isolated enzyme and the effects of compounds on cells were largely unaffected by the kinase conformation bound.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18602262 DOI: 10.1016/j.bmcl.2008.06.028
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823